DLA Piper – The United States Food and Drug Administration (FDA) has released updated cybersecurity guidance titled Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions – Guidance for Industry and Food and Drug Administration Staff (Guidance), reflecting the agency’s response to the growing integration of wireless and network connected capabilities in medical devices, which has made cybersecurity controls central to device safety and effectiveness.
Cybersecurity, Privacy, & AI
Trending Now
Daybreak Is OpenAI’s Answer to the AI Arms Race in Cybersecurity • Cyber Operations Aren’t Slow — Our Thinking Is • ‘No Time to Waste’ in Prepping Governments for AI Cyber Threats, Top Dem Lawmaker Says • ‘Insatiable Appetite’ for AI: Maven Usage Surged for Strikes on Iran, Pentagon AI Chief Says • Navigating Automation, Robotics, AI, and Data in a QMSR-Driven Manufacturing World
FDA Issues Revised Cybersecurity Premarket Submission Guidance to Align With Quality Management System Regulation
bangoland | Shutterstock
Stay compliant and protected with daily updates on cybersecurity, data privacy, and federal oversight with our Cyber & Privacy newsletter, delivering up-to-the-minute intelligence Monday–Saturday — Subscribe here.